Punit Dhillon

CIK 1425052 · View on SEC EDGAR ↗

Insider

First SEC filing: Jan. 23, 2018 · Latest: Jan. 23, 2018

On this page

Insider at

Insider transactions

0 buys (P) 0 sells (S) Net: $0 + 6 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

No open-market trades on record; showing all filings.

Date Ticker Code Shares Price Value Owned after Δ own A/D vs now
Aug. 7, 2026 SKYE A 1,090,000 1,419,823 Direct +330.48% Acquired (price as of 2026-08-19)
Oct. 10, 2018 SKYE A 200,000 200,000 Direct Acquired (price as of 2026-08-19)
Sept. 30, 2009 INO A 75,000 $1.57 $117,750 75,000 Direct Acquired -98.4% (price as of 2026-08-19)
Dec. 9, 2008 INO A 70,000 $0.50 $35,000 70,000 Direct Acquired -94.9% (price as of 2026-08-19)
July 9, 2008 INO A 60,000 $1.06 $63,600 60,000 Direct Acquired -97.6% (price as of 2026-08-19)
Feb. 1, 2008 INO A 50,000 $0.87 $43,500 50,000 Direct Acquired -97.0% (price as of 2026-08-19)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II)

Options, RSUs and convertible securities reported on Form 4 Table II.

Date Ticker Security Underlying Exercise price Expiration Shares A/D
Oct. 10, 2018 SKYE Director Stock Option (Right to Buy) Common Stock (200,000) $0.30 Oct. 10, 2028 200,000 Acquired
Sept. 30, 2009 INO Common Stock Option Common Stock (75,000) $1.57 Sept. 30, 2019 75,000 Acquired
Dec. 9, 2008 INO Common Stock Option Common Stock (70,000) $0.50 Dec. 9, 2018 70,000 Acquired
July 9, 2008 INO Common Stock Option Common Stock (60,000) $1.06 July 9, 2018 60,000 Acquired
Feb. 1, 2008 INO Common Stock Option Common Stock (50,000) $0.87 Feb. 1, 2018 50,000 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 9 holdings

Securities held when first becoming an insider, per SEC Form 3.

Date Ticker Security Shares Ownership
Jan. 23, 2018 SKYE No securities beneficially owned. 0 Direct
Jan. 30, 2008 INO Inovio Biomedical Corporation Common Stock 185 Direct
Jan. 30, 2008 INO Inovio Biomedical Corporation Common Stock Option→ Inovio Biomedical Corporation Common Stock (25,000) 25,000 Direct
Jan. 30, 2008 INO Inovio Biomedical Corporation Common Stock Option→ Inovio Biomedical Corporation Common Stock (6,250) 6,250 Direct
Jan. 30, 2008 INO Inovio Biomedical Corporation Common Stock Option→ Inovio Biomedical Corporation Common Stock (15,000) 15,000 Direct
Jan. 30, 2008 INO Inovio Biomedical Corporation Common Stock Option→ Inovio Biomedical Corporation Common Stock (35,000) 35,000 Direct
Jan. 30, 2008 INO Inovio Biomedical Corporation Common Stock Option→ Inovio Biomedical Corporation Common Stock (40,000) 40,000 Direct
Jan. 30, 2008 INO Inovio Biomedical Corporation Common Stock Option→ Inovio Biomedical Corporation Common Stcok (15,000) 15,000 Direct
Jan. 30, 2008 INO Inovio Biomedical Corporation Common Stock Warrants→ Inovio Biomedical Corporation Common Stock (1,029) 1,029 Direct

Compensation (DEF 14A)

Matched by name from proxy statements (DEF 14A) — verify against the filing.

INO

Fiscal year Salary Bonus Stock awards Option awards Non-equity incentive Pension change Other Total
2008 $171,876 $85,517 $3,900 $261,293
2007 $145,736 $13,300 $94,025 $3,900 $256,961

SKYE

CEO
Fiscal year Salary Bonus Stock awards Option awards Non-equity incentive Pension change Other Total
2025 $610,000 $219,600 $1,361,831
2024 $458,333 $255,763 $6,139,625
2023 $450,000 $270,000 $1,807,338

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.